Blood Stem Cell Mobilization in Solid Tumors: Experience with Plerixafor and Alternative Ways of Hematopoietic Stem Cell Mobilization View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

2011-12-20

AUTHORS

Guido Kobbe , Rainer Haas

ABSTRACT

High-dose therapy and autologous hematopoietic stem cell transplantation has traditionally been used to treat patients with high-risk hematologic malignancies. In addition, there are some rare solid tumors in children, adolescent, or young adults that may also be treated successfully with high-dose therapy. These include neuroblastoma, medulloblastoma, and Ewing’s sarcoma as well as some types of germ cell tumors. In patients suffering from these tumors, blood stem cells have so far been mobilized by G-CSF or GM-CSF alone during steady-state hematopoiesis or in combination with cytotoxic therapy. If treated for recurrent disease, up to 30% of these patients fail traditional mobilization regimens due to extensive pretreatment. Recent evidence suggests that the CXCR4 antagonist Plerixafor may be used to enhance G-CSF mediated mobilization allowing sufficient blood stem cell collections in these so-called “poor mobilizers.” This chapter reviews the current literature on the use of Plerixafor in patients with solid tumors and highlights additional experimental agents for blood stem cell mobilization. More... »

PAGES

247-262

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-1-4614-1960-0_13

DOI

http://dx.doi.org/10.1007/978-1-4614-1960-0_13

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1008554651


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Oncology and Clinical Immunology, University Hospital D\u00fcsseldorf, Heinrich Heine University D\u00fcsseldorf, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/grid.411327.2", 
          "name": [
            "Department of Hematology, Oncology and Clinical Immunology, University Hospital D\u00fcsseldorf, Heinrich Heine University D\u00fcsseldorf, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kobbe", 
        "givenName": "Guido", 
        "id": "sg:person.01164073234.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01164073234.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Oncology and Clinical Immunology, University Hospital D\u00fcsseldorf, Heinrich Heine University D\u00fcsseldorf, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/grid.411327.2", 
          "name": [
            "Department of Hematology, Oncology and Clinical Immunology, University Hospital D\u00fcsseldorf, Heinrich Heine University D\u00fcsseldorf, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Haas", 
        "givenName": "Rainer", 
        "id": "sg:person.01127414674.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127414674.14"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2011-12-20", 
    "datePublishedReg": "2011-12-20", 
    "description": "High-dose therapy and autologous hematopoietic stem cell transplantation has traditionally been used to treat patients with high-risk hematologic malignancies. In addition, there are some rare solid tumors in children, adolescent, or young adults that may also be treated successfully with high-dose therapy. These include neuroblastoma, medulloblastoma, and Ewing\u2019s sarcoma as well as some types of germ cell tumors. In patients suffering from these tumors, blood stem cells have so far been mobilized by G-CSF or GM-CSF alone during steady-state hematopoiesis or in combination with cytotoxic therapy. If treated for recurrent disease, up to 30% of these patients fail traditional mobilization regimens due to extensive pretreatment. Recent evidence suggests that the CXCR4 antagonist Plerixafor may be used to enhance G-CSF mediated mobilization allowing sufficient blood stem cell collections in these so-called \u201cpoor mobilizers.\u201d This chapter reviews the current literature on the use of Plerixafor in patients with solid tumors and highlights additional experimental agents for blood stem cell mobilization.", 
    "editor": [
      {
        "familyName": "Fruehauf", 
        "givenName": "Stefan", 
        "type": "Person"
      }, 
      {
        "familyName": "Zeller", 
        "givenName": "W. Jens", 
        "type": "Person"
      }, 
      {
        "familyName": "Calandra", 
        "givenName": "Gary", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-1-4614-1960-0_13", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-1-4614-1959-4", 
        "978-1-4614-1960-0"
      ], 
      "name": "Novel Developments in Stem Cell Mobilization", 
      "type": "Book"
    }, 
    "keywords": [
      "stem cell mobilization", 
      "blood stem cell mobilization", 
      "high-dose therapy", 
      "cell mobilization", 
      "solid tumors", 
      "G-CSF", 
      "autologous hematopoietic stem cell transplantation", 
      "high-risk hematologic malignancies", 
      "hematopoietic stem cell transplantation", 
      "blood stem cell collection", 
      "rare solid tumors", 
      "stem cell transplantation", 
      "CXCR4 antagonist plerixafor", 
      "germ cell tumors", 
      "hematopoietic stem cell mobilization", 
      "blood stem cells", 
      "use of plerixafor", 
      "stem cell collection", 
      "recurrent disease", 
      "cell transplantation", 
      "cytotoxic therapy", 
      "mobilization regimens", 
      "cell tumors", 
      "poor mobilizers", 
      "hematologic malignancies", 
      "Ewing's sarcoma", 
      "patients", 
      "experimental agents", 
      "GM-CSF", 
      "tumors", 
      "cell collection", 
      "plerixafor", 
      "therapy", 
      "young adults", 
      "Recent evidence", 
      "sarcoma", 
      "steady-state hematopoiesis", 
      "current literature", 
      "stem cells", 
      "mobilization", 
      "regimens", 
      "transplantation", 
      "malignancy", 
      "neuroblastoma", 
      "medulloblastoma", 
      "disease", 
      "extensive pretreatment", 
      "adults", 
      "children", 
      "adolescents", 
      "hematopoiesis", 
      "mobilizers", 
      "pretreatment", 
      "cells", 
      "agents", 
      "evidence", 
      "use", 
      "combination", 
      "literature", 
      "addition", 
      "types", 
      "collection", 
      "chapter", 
      "alternative way", 
      "way"
    ], 
    "name": "Blood Stem Cell Mobilization in Solid Tumors: Experience with Plerixafor and Alternative Ways of Hematopoietic Stem Cell Mobilization", 
    "pagination": "247-262", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1008554651"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-1-4614-1960-0_13"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-1-4614-1960-0_13", 
      "https://app.dimensions.ai/details/publication/pub.1008554651"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2022-08-04T17:18", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/chapter/chapter_327.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-1-4614-1960-0_13"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-1-4614-1960-0_13'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-1-4614-1960-0_13'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-1-4614-1960-0_13'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-1-4614-1960-0_13'


 

This table displays all metadata directly associated to this object as RDF triples.

141 TRIPLES      22 PREDICATES      88 URIs      81 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-1-4614-1960-0_13 schema:about anzsrc-for:11
2 anzsrc-for:1102
3 schema:author Ne478612ea2fc4e2bb1778d1601100b31
4 schema:datePublished 2011-12-20
5 schema:datePublishedReg 2011-12-20
6 schema:description High-dose therapy and autologous hematopoietic stem cell transplantation has traditionally been used to treat patients with high-risk hematologic malignancies. In addition, there are some rare solid tumors in children, adolescent, or young adults that may also be treated successfully with high-dose therapy. These include neuroblastoma, medulloblastoma, and Ewing’s sarcoma as well as some types of germ cell tumors. In patients suffering from these tumors, blood stem cells have so far been mobilized by G-CSF or GM-CSF alone during steady-state hematopoiesis or in combination with cytotoxic therapy. If treated for recurrent disease, up to 30% of these patients fail traditional mobilization regimens due to extensive pretreatment. Recent evidence suggests that the CXCR4 antagonist Plerixafor may be used to enhance G-CSF mediated mobilization allowing sufficient blood stem cell collections in these so-called “poor mobilizers.” This chapter reviews the current literature on the use of Plerixafor in patients with solid tumors and highlights additional experimental agents for blood stem cell mobilization.
7 schema:editor N8f5f736bfe3b4fa9ad4b424487c61b13
8 schema:genre chapter
9 schema:isAccessibleForFree false
10 schema:isPartOf N180869823ec44ef48b1ab504bc3bb077
11 schema:keywords CXCR4 antagonist plerixafor
12 Ewing's sarcoma
13 G-CSF
14 GM-CSF
15 Recent evidence
16 addition
17 adolescents
18 adults
19 agents
20 alternative way
21 autologous hematopoietic stem cell transplantation
22 blood stem cell collection
23 blood stem cell mobilization
24 blood stem cells
25 cell collection
26 cell mobilization
27 cell transplantation
28 cell tumors
29 cells
30 chapter
31 children
32 collection
33 combination
34 current literature
35 cytotoxic therapy
36 disease
37 evidence
38 experimental agents
39 extensive pretreatment
40 germ cell tumors
41 hematologic malignancies
42 hematopoiesis
43 hematopoietic stem cell mobilization
44 hematopoietic stem cell transplantation
45 high-dose therapy
46 high-risk hematologic malignancies
47 literature
48 malignancy
49 medulloblastoma
50 mobilization
51 mobilization regimens
52 mobilizers
53 neuroblastoma
54 patients
55 plerixafor
56 poor mobilizers
57 pretreatment
58 rare solid tumors
59 recurrent disease
60 regimens
61 sarcoma
62 solid tumors
63 steady-state hematopoiesis
64 stem cell collection
65 stem cell mobilization
66 stem cell transplantation
67 stem cells
68 therapy
69 transplantation
70 tumors
71 types
72 use
73 use of plerixafor
74 way
75 young adults
76 schema:name Blood Stem Cell Mobilization in Solid Tumors: Experience with Plerixafor and Alternative Ways of Hematopoietic Stem Cell Mobilization
77 schema:pagination 247-262
78 schema:productId N16c7193a9c2143c18258284d2cc6e1a2
79 N60d82dcc558445c6897e8ffc763c372c
80 schema:publisher Nbcccb1f043a847bfbc332789e43340ea
81 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008554651
82 https://doi.org/10.1007/978-1-4614-1960-0_13
83 schema:sdDatePublished 2022-08-04T17:18
84 schema:sdLicense https://scigraph.springernature.com/explorer/license/
85 schema:sdPublisher Ncacc9513641f44aeb3fbd7a329c7c954
86 schema:url https://doi.org/10.1007/978-1-4614-1960-0_13
87 sgo:license sg:explorer/license/
88 sgo:sdDataset chapters
89 rdf:type schema:Chapter
90 N14798d254f814697b0cc5d4466d91ed1 rdf:first Nb89a66f983a54d64814342b8896dbb20
91 rdf:rest Nfdfca1aa95a64877816dbec89b053f4f
92 N16c7193a9c2143c18258284d2cc6e1a2 schema:name dimensions_id
93 schema:value pub.1008554651
94 rdf:type schema:PropertyValue
95 N180869823ec44ef48b1ab504bc3bb077 schema:isbn 978-1-4614-1959-4
96 978-1-4614-1960-0
97 schema:name Novel Developments in Stem Cell Mobilization
98 rdf:type schema:Book
99 N1b669c7009574cb8b3c1636d8c0972bb rdf:first sg:person.01127414674.14
100 rdf:rest rdf:nil
101 N60d82dcc558445c6897e8ffc763c372c schema:name doi
102 schema:value 10.1007/978-1-4614-1960-0_13
103 rdf:type schema:PropertyValue
104 N8f5f736bfe3b4fa9ad4b424487c61b13 rdf:first Ndc0c7ad97a5b422a877fd1bce8002ef8
105 rdf:rest N14798d254f814697b0cc5d4466d91ed1
106 Nb89a66f983a54d64814342b8896dbb20 schema:familyName Zeller
107 schema:givenName W. Jens
108 rdf:type schema:Person
109 Nbb01e037877f40b4bbd6693f8e83437c schema:familyName Calandra
110 schema:givenName Gary
111 rdf:type schema:Person
112 Nbcccb1f043a847bfbc332789e43340ea schema:name Springer Nature
113 rdf:type schema:Organisation
114 Ncacc9513641f44aeb3fbd7a329c7c954 schema:name Springer Nature - SN SciGraph project
115 rdf:type schema:Organization
116 Ndc0c7ad97a5b422a877fd1bce8002ef8 schema:familyName Fruehauf
117 schema:givenName Stefan
118 rdf:type schema:Person
119 Ne478612ea2fc4e2bb1778d1601100b31 rdf:first sg:person.01164073234.53
120 rdf:rest N1b669c7009574cb8b3c1636d8c0972bb
121 Nfdfca1aa95a64877816dbec89b053f4f rdf:first Nbb01e037877f40b4bbd6693f8e83437c
122 rdf:rest rdf:nil
123 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
124 schema:name Medical and Health Sciences
125 rdf:type schema:DefinedTerm
126 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
127 schema:name Cardiorespiratory Medicine and Haematology
128 rdf:type schema:DefinedTerm
129 sg:person.01127414674.14 schema:affiliation grid-institutes:grid.411327.2
130 schema:familyName Haas
131 schema:givenName Rainer
132 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127414674.14
133 rdf:type schema:Person
134 sg:person.01164073234.53 schema:affiliation grid-institutes:grid.411327.2
135 schema:familyName Kobbe
136 schema:givenName Guido
137 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01164073234.53
138 rdf:type schema:Person
139 grid-institutes:grid.411327.2 schema:alternateName Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany
140 schema:name Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany
141 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...